SNPs associates with a higher cancer risk; inhibits ER-dependent tumor growth; deficiency correlates with tumor growth, an increased sensitivity to estrogen-induced cell proliferation, and impaired Nod1-dependent apoptosis; reduced cell proliferation and increased clonogenic potential in vitro. This evidence concerns the gene ESR1 and cancer.